A Phase 1 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M07D1 in Subjects With HER2 Expressing Advanced Malignant Solid Tumors
NCT06293898 · RECRUITING · Phase 1
We track 1 ClinicalTrials.gov studies led by Systimmune Inc. The portfolio skews toward Phase 1 (1 trials).
1 clinical trials sponsored by Systimmune Inc.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 1 | 1 | 100% |
Systimmune Inc currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 1.
Systimmune Inc conducts research across multiple therapeutic areas. Browse the trial listings for details.
Yes, Systimmune Inc currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.